Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Evolutionary characteristics of intergenic transcribed regions indicate rare novel genes and widespread noisy transcription in the Poaceae.

Lloyd JP, Bowman MJ, Azodi CB, Sowers RP, Moghe GD, Childs KL, Shiu SH.

Sci Rep. 2019 Aug 20;9(1):12122. doi: 10.1038/s41598-019-47797-y.

2.

Virtual Reality, Visual Cliffs, and Movement Disorders.

Kaur R, Lin X, Layton A, Hernandez M, Sowers R.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:81-84. doi: 10.1109/EMBC.2018.8512246.

PMID:
30440346
3.

A Model-Based Approach for Identifying Functional Intergenic Transcribed Regions and Noncoding RNAs.

Lloyd JP, Tsai ZT, Sowers RP, Panchy NL, Shiu SH.

Mol Biol Evol. 2018 Jun 1;35(6):1422-1436. doi: 10.1093/molbev/msy035.

PMID:
29554332
4.

Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma model.

Yang Y, Yang R, Roth M, Piperdi S, Zhang W, Dorfman H, Rao P, Park A, Tripathi S, Freeman C, Zhang Y, Sowers R, Rosenblum J, Geller D, Hoang B, Gill J, Gorlick R.

Genes Cancer. 2017 Jan;8(1-2):484-494. doi: 10.18632/genesandcancer.133.

5.

Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma.

Cao Y, Roth M, Piperdi S, Montoya K, Sowers R, Rao P, Geller D, Houghton P, Kolb EA, Gill J, Gorlick R.

PLoS One. 2014 Aug 29;9(8):e106249. doi: 10.1371/journal.pone.0106249. eCollection 2014.

6.

Resilience and professional quality of life among military healthcare providers.

Leners C, Sowers R, Quinn Griffin MT, Fitzpatrick JJ.

Issues Ment Health Nurs. 2014 Jul;35(7):497-502. doi: 10.3109/01612840.2014.887164.

PMID:
24963849
7.

HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study.

Gorlick S, Barkauskas DA, Krailo M, Piperdi S, Sowers R, Gill J, Geller D, Randall RL, Janeway K, Schwartz C, Grier H, Meyers PA, Gorlick R, Bernstein M, Marina N.

Pediatr Blood Cancer. 2014 Sep;61(9):1558-64. doi: 10.1002/pbc.25074. Epub 2014 Apr 22.

8.

Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma.

Roth M, Linkowski M, Tarim J, Piperdi S, Sowers R, Geller D, Gill J, Gorlick R.

Cancer. 2014 Feb 15;120(4):548-54. doi: 10.1002/cncr.28461. Epub 2013 Oct 25.

9.

Impairment of methotrexate transport is common in osteosarcoma tumor samples.

Sowers R, Wenzel BD, Richardson C, Meyers PA, Healey JH, Levy AS, Gorlick R.

Sarcoma. 2011;2011:834170. doi: 10.1155/2011/834170. Epub 2010 Dec 22.

10.

Tumour interstitial fluid pressure may regulate angiogenic factors in osteosarcoma.

Nathan SS, Huvos AG, Casas-Ganem JE, Yang R, Linkov I, Sowers R, DiResta GR, Gorlick R, Healey JH.

Ann Acad Med Singapore. 2009 Dec;38(12):1041-7.

11.

Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance.

Humeniuk R, Menon LG, Mishra PJ, Gorlick R, Sowers R, Rode W, Pizzorno G, Cheng YC, Kemeny N, Bertino JR, Banerjee D.

Mol Cancer Ther. 2009 May;8(5):1037-44. doi: 10.1158/1535-7163.MCT-08-0716. Epub 2009 Apr 21.

12.

Tumor interstitial fluid pressure may regulate angiogenic factors in osteosarcoma.

Nathan SS, Huvos AG, Casas-Ganem JE, Yang R, Linkov I, Sowers R, DiResta GR, Gorlick R, Healey JH.

J Orthop Res. 2008 Nov;26(11):1520-5. doi: 10.1002/jor.20633.

13.

Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.

Kubo T, Piperdi S, Rosenblum J, Antonescu CR, Chen W, Kim HS, Huvos AG, Sowers R, Meyers PA, Healey JH, Gorlick R.

Cancer. 2008 May 15;112(10):2119-29. doi: 10.1002/cncr.23437.

14.

Impairments in antifolate transport are common in retinoblastoma tumor samples.

Gorlick RG, Abramson DH, Sowers R, Mazza BA, Dunkel IJ.

Pediatr Blood Cancer. 2008 Mar;50(3):573-6.

PMID:
17554792
15.

The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate.

Yang R, Kolb EA, Qin J, Chou A, Sowers R, Hoang B, Healey JH, Huvos AG, Meyers PA, Gorlick R.

Clin Cancer Res. 2007 May 1;13(9):2557-67.

16.

Over-expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcoma.

Yang R, Hoang BH, Kubo T, Kawano H, Chou A, Sowers R, Huvos AG, Meyers PA, Healey JH, Gorlick R.

Int J Cancer. 2007 Sep 1;121(5):943-54.

17.

FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.

Cheung NK, Sowers R, Vickers AJ, Cheung IY, Kushner BH, Gorlick R.

J Clin Oncol. 2006 Jun 20;24(18):2885-90. Epub 2006 May 8. Erratum in: J Clin Oncol. 2006 Aug 10;24(23):3814.

PMID:
16682723
18.

Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma.

Laverdiere C, Hoang BH, Yang R, Sowers R, Qin J, Meyers PA, Huvos AG, Healey JH, Gorlick R.

Clin Cancer Res. 2005 Apr 1;11(7):2561-7.

19.

Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma.

Nathan SS, DiResta GR, Casas-Ganem JE, Hoang BH, Sowers R, Yang R, Huvos AG, Gorlick R, Healey JH.

Clin Cancer Res. 2005 Mar 15;11(6):2389-97.

20.

An expression signature classifies chemotherapy-resistant pediatric osteosarcoma.

Mintz MB, Sowers R, Brown KM, Hilmer SC, Mazza B, Huvos AG, Meyers PA, Lafleur B, McDonough WS, Henry MM, Ramsey KE, Antonescu CR, Chen W, Healey JH, Daluski A, Berens ME, Macdonald TJ, Gorlick R, Stephan DA.

Cancer Res. 2005 Mar 1;65(5):1748-54.

21.

Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors.

Kortmansky J, Shah MA, Kaubisch A, Weyerbacher A, Yi S, Tong W, Sowers R, Gonen M, O'reilly E, Kemeny N, Ilson DI, Saltz LB, Maki RG, Kelsen DP, Schwartz GK.

J Clin Oncol. 2005 Mar 20;23(9):1875-84. Epub 2005 Feb 7.

PMID:
15699481
22.

Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma.

Hoang BH, Kubo T, Healey JH, Sowers R, Mazza B, Yang R, Huvos AG, Meyers PA, Gorlick R.

Int J Cancer. 2004 Mar;109(1):106-11.

23.

Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: a Children's Cancer Group Study.

Levy AS, Sather HN, Steinherz PG, Sowers R, La M, Moscow JA, Gaynon PS, Uckun FM, Bertino JR, Gorlick R; Children's Cancer Group Study.

J Pediatr Hematol Oncol. 2003 Sep;25(9):688-95.

PMID:
12972803
24.

mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma.

Sowers R, Toguchida J, Qin J, Meyers PA, Healey JH, Huvos A, Banerjee D, Bertino JR, Gorlick R.

Mol Cancer Ther. 2003 Jun;2(6):535-41.

25.

Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples.

Yang R, Sowers R, Mazza B, Healey JH, Huvos A, Grier H, Bernstein M, Beardsley GP, Krailo MD, Devidas M, Bertino JR, Meyers PA, Gorlick R.

Clin Cancer Res. 2003 Feb;9(2):837-44.

26.

Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.

GarcĂ­a-Castellano JM, Villanueva A, Healey JH, Sowers R, Cordon-Cardo C, Huvos A, Bertino JR, Meyers P, Gorlick R.

Clin Cancer Res. 2002 Mar;8(3):782-7.

27.

Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-glycoprotein expression in high-grade osteosarcoma.

Gorlick R, Liao AC, Antonescu C, Huvos AG, Healey JH, Sowers R, Daras M, Calleja E, Wexler LH, Panicek D, Meyers PA, Yeh SD, Larson SM.

Clin Cancer Res. 2001 Oct;7(10):3065-70.

29.

Management of common obstetric problems: panel discussion.

ADLER P, MINES JL 3rd, NORTON CK, ELLIS NG, SOWERS RE.

J Am Osteopath Assoc. 1961 Feb;60:451-7. No abstract available.

PMID:
13681504
30.

Fetal effects of maternal toxemias.

SOWERS RE.

J Am Osteopath Assoc. 1954 Jun;53(10):577-8. No abstract available.

PMID:
13162877
31.

Physiology of early ambulation.

SOWERS RE.

J Am Osteopath Assoc. 1949 Jul;48(11):595-8. No abstract available.

PMID:
18152734

Supplemental Content

Loading ...
Support Center